Gastric Adenocarcinoma
Showing NaN - NaN of 8
Metastatic Solid Tumors, NSCLC, Melanoma Trial in United States (INBRX-105 - PDL1x41BB antibody, Pembrolizumab)
Recruiting
- Metastatic Solid Tumors
- +7 more
- INBRX-105 - PDL1x41BB antibody
- Pembrolizumab
-
Scottsdale, Arizona
- +12 more
Jan 26, 2023
Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Atlanta (Nanoliposomal
Recruiting
- Colorectal Adenocarcinoma
- +13 more
- Nanoliposomal Irinotecan
- Trifluridine and Tipiracil Hydrochloride
-
Atlanta, Georgia
- +2 more
Jan 6, 2023
Epstein-Barr Virus Positive, Gastric Adenocarcinoma, Mismatch Repair Protein Deficiency Trial in New Brunswick (drug, other,
Recruiting
- Epstein-Barr Virus Positive
- +10 more
- Capecitabine
- +3 more
-
Atlanta, Georgia
- +2 more
Dec 10, 2022
Gastric Adenocarcinoma, Esophageal Adenocarcinoma, Metastasis Trial in United States (Oxaliplatin, Leucovorin, 5 fluorouracil)
Active, not recruiting
- Gastric Adenocarcinoma
- +3 more
- Oxaliplatin
- +4 more
-
Duarte, California
- +6 more
May 10, 2021
Adenocarcinoma of the Gastroesophageal Junction, Gastric Adenocarcinoma, Gastric Cancer Trial in United States (procedure, drug,
Terminated
- Adenocarcinoma of the Gastroesophageal Junction
- +2 more
- FDG-PET
- +7 more
-
Los Angeles, California
- +70 more
Sep 10, 2019
NSCLC, Carcinoma, Renal Cell, Breast Tumors Trial in United States (SGN-2FF, pembrolizumab)
Terminated
- Carcinoma, Non-Small-Cell Lung
- +7 more
-
Birmingham, Alabama
- +10 more
Jul 17, 2019
Gastric Adenocarcinoma Trial in Atlanta (Gleevec, Taxotere)
Terminated
- Gastric Adenocarcinoma
- Gleevec, Taxotere
-
Atlanta, GeorgiaEmory University Winship Cancer Institute
Dec 27, 2007